Dymax, global manufacturer of rapid-curing materials and equipment, is introducing its new 2000-MW series of light-curable adhesives, which were specifically developed to address customer requirements and market trends within the rapidly evolving medical-device wearables market.
This new range of structural medical adhesives are the first to pass the ISO 10993-10 for sensitization and irritation. This means that they’re free from TPO (a material of concern) and made without IBOA, a known skin irritant.
The new adhesives aptly address device manufacturers’ concerns about skin proximity and sensitivity.
Designed for bonding SS, PC, PI, PVC, TPU, and low-surface energy substrates, the 2000-MW series are also engineered for reliability with excellent adhesion and aging performance. The new adhesives cure with broad-spectrum light energy and some products provide durable protection during autoclave sterilization.
“Staying true to our core values while addressing the evolving needs of our customers, Dymax continues to develop innovative light-curable adhesives. Removing materials of concern with the introduction of the 2000-MW series of products is our first step toward the elimination of problematic ingredients, ”said Mike Ford, Global Business Development director — Medical for Dymax.
These adhesives are environmentally friendly, one-part formulations, solvent-free, and meet ISO 10993-5 cytotoxicity biocompatibility requirements.
Typical applications include devices worn in close proximity to the skin, such as continuous glucose monitors, large volume injectors, patient monitoring devices, and pain-management devices. Fluorescing grades are available for high-speed automated vision systems used for quality-control purposes.
The 2000-MW series’ features…
- Cure using LED or UV/Visible light
- Medical-grade formulas available
- One part formulation, so no mixing necessary
- Passes ISO 10993-10 for sensitization and irritation (some products)
- ISO 10993-5 cytotoxicity
- Made without IBOA and TPO (some products)